Maddi Hebebrand, MC, Associate Editor

PASI and DLQI scores are closely linked, but stigma and residual effects may still impact patient QoL.

Explore the top headlines of the week including insights on clinical trials, CBD products, and more.

This week, we feature top articles from our sister publications on clinical trials, FDA updates, and more.

Explore the top headlines of the week including insights on recalls, expert pearls, and more.

With an increasing demand for laser procedures, AI-based skin assessments may help ensure safer and more effective treatments.

The cream contains barrier-repairing ingredients that may enhance self-healing and hydration in affected skin.

Nearly half of patients with melanoma experience significant distress, affecting treatment adherence and quality of life.

Researchers behind a recent review shared expert insights, treatment guidelines, and differential diagnosis techniques for pediatric rosacea.

Targeting type 2 cytokines with monoclonal antibodies has revolutionized treatment for inflammatory skin diseases, reducing symptoms and improving quality of life.

An expert panel of clinicians provided insights on first-line treatments, maintenance strategies, and flare management for AD.

Research suggests that neomycin allergy may be underdiagnosed despite its common use in medical and cosmetic formulations.

The study identified 2 fungal profiles in AD patients, with 1 subgroup exhibiting distinct fungal dysbiosis.

Researchers have identified elevated eosinophil levels as a potential marker for chronic urticaria in pediatric patients.

Explore the top headlines of the week including insights on voluntary recalls, DIMIDs and pandemic risks, and AAD pearls.

This week, we feature top articles from our sister publications on long COVID recovery, integrating AI into pharmacy, and more.

At week 24, the proportion of Asian patients achieving significant hair regrowth (SALT ≤20) was substantially higher in ritlecitinib treatment groups than in placebo groups.

Participants reported increased confidence in clinical interactions and greater interest in dermatology as a career path.

Nail psoriasis affects 50% of plaque psoriasis patients, making effective treatments crucial.

A recent study highlights the need for ophthalmologic monitoring in pediatric dupilumab therapy.

The investigational drug, designed using AI technology, optimizes pharmacologic characteristics for psoriasis treatment.

The expert discussion focused on patient management strategies, treatment modalities, and the role of multidisciplinary collaboration.

A pilot study revealed that mitochondrial complex I-blocking drugs, like metformin and berberine, improved TSW symptoms in most participants.

Join Dermatology Times in celebrating the women who make this field shine through their patient interactions, clinical insights, and research.

Tomassian noted unrealistic beauty standards fueled by social media filters and edited images have led to distorted expectations.

Explore the top headlines of the week including insights on L'Oréal’s voluntary recall of benzoyl peroxide products, the impact of GLP-1 medications on skin health, and more 2025 conferences.

This week, we feature top articles from our sister publications on FDA updates, Medicaid pricing, and more.

A study analyzed TikTok’s top 50 videos on hyperpigmentation in skin of color, revealing a discrepancy between engagement and medical accuracy.

By staying authentic and leveraging real patient experiences, Tomassian ensures his content remains valuable and trustworthy.

An analysis of 70 studies shows that MMS reduces local recurrence to 5.0% compared to 17.7% for WLE in anogenital SCC cases.

By leveraging the innovative biomarker panels, clinicians can now offer more personalized and effective treatment options for psoriasis and AD.